M Blumenstein

1.5k total citations
43 papers, 1.2k citations indexed

About

M Blumenstein is a scholar working on Nephrology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M Blumenstein has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 12 papers in Immunology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M Blumenstein's work include Dialysis and Renal Disease Management (10 papers), Immune Response and Inflammation (6 papers) and Electrolyte and hormonal disorders (5 papers). M Blumenstein is often cited by papers focused on Dialysis and Renal Disease Management (10 papers), Immune Response and Inflammation (6 papers) and Electrolyte and hormonal disorders (5 papers). M Blumenstein collaborates with scholars based in Germany, United States and Croatia. M Blumenstein's co-authors include M Ströbel, A Pforte, Bernward Passlick, B. Schmidt, H. J. Gurland, H.W.L. Ziegler-Heitbrock, W. Samtleben, Günter Fingerle‐Rowson, Thomas Bosch and Peter Fraunberger and has published in prestigious journals such as Blood, Kidney International and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

M Blumenstein

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Blumenstein Germany 17 624 170 157 149 122 43 1.2k
Erik Hack Netherlands 14 633 1.0× 116 0.7× 210 1.3× 88 0.6× 148 1.2× 19 1.2k
Marie‐Alexandra Alyanakian France 20 548 0.9× 148 0.9× 352 2.2× 201 1.3× 111 0.9× 34 1.4k
C. Edward Rose United States 14 604 1.0× 122 0.7× 208 1.3× 190 1.3× 43 0.4× 23 1.3k
Hanan Gur Israel 17 541 0.9× 204 1.2× 173 1.1× 139 0.9× 58 0.5× 35 1.2k
A. Ting United Kingdom 24 619 1.0× 238 1.4× 118 0.8× 455 3.1× 225 1.8× 79 1.7k
Aliakbar Amirzargar Iran 18 512 0.8× 157 0.9× 163 1.0× 243 1.6× 82 0.7× 79 1.1k
Antonij Slavčev Czechia 19 333 0.5× 138 0.8× 149 0.9× 327 2.2× 94 0.8× 75 1.0k
M Ben-Bassat Israel 20 285 0.5× 142 0.8× 202 1.3× 209 1.4× 75 0.6× 73 1.2k
Stephan Regenass Switzerland 19 324 0.5× 177 1.0× 223 1.4× 156 1.0× 53 0.4× 40 1.2k
Othmar Ludwiczek Austria 14 403 0.6× 332 2.0× 250 1.6× 184 1.2× 267 2.2× 19 1.3k

Countries citing papers authored by M Blumenstein

Since Specialization
Citations

This map shows the geographic impact of M Blumenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Blumenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Blumenstein more than expected).

Fields of papers citing papers by M Blumenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Blumenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Blumenstein. The network helps show where M Blumenstein may publish in the future.

Co-authorship network of co-authors of M Blumenstein

This figure shows the co-authorship network connecting the top 25 collaborators of M Blumenstein. A scholar is included among the top collaborators of M Blumenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Blumenstein. M Blumenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bosch, Thomas, B. Schmidt, M Blumenstein, & H. J. Gurland. (2015). Thrombogenicity Markers in Clinical and ex vivo Assessment of Membrane Biocompatibility. Contributions to nephrology. 59. 90–98.
2.
Moran, John, M Blumenstein, & H. J. Gurland. (2015). Immunodeficiencies in Chronic Renal Failure. Contributions to nephrology. 86. 91–110.
3.
Schwenger, Vedat, Ralf Westenfeld, Thomas Weinreich, et al.. (2014). Dialyse- und Ultrafiltrationsverfahren bei kardiorenalem Syndrom. Der Kardiologe. 8(1). 26–35. 4 indexed citations
4.
Blumenstein, M, et al.. (2008). Nierenbeteiligung bei progressiver Sklerodermie. DMW - Deutsche Medizinische Wochenschrift. 122(7). 200–204.
5.
Samtleben, W. & M Blumenstein. (1999). Indikation und Auswahl der Dialyseverfahren bei akuter und chronischer Niereninsuffizienz einschließlich kontinuierlicher Verfahren. Der Internist. 40(1). 3–12. 3 indexed citations
6.
Odell, Ross A., et al.. (1998). Dialysis neutropenia: The role of the cytoskeleton. Kidney International. 53(3). 783–789. 21 indexed citations
7.
Fingerle‐Rowson, Günter, et al.. (1998). Expansion of CD14+CD16+Monocytes in Critically Ill Cardiac Surgery Patients. Inflammation. 22(4). 367–379. 58 indexed citations
8.
Fingerle‐Rowson, Günter, et al.. (1998). Down-regulation of surface monocyte lipopolysaccharide-receptor cd14 in patients on cardiopulmonary bypass undergoing aorta-coronary bypass operation. Journal of Thoracic and Cardiovascular Surgery. 115(5). 1172–1178. 20 indexed citations
9.
Blumenstein, M, Peter Boekstegers, Peter Fraunberger, et al.. (1997). CYTOKINE PRODUCTION PRECEDES THE EXPANSION OF CD14+CD16+ MONOCYTES IN HUMAN SEPSIS. Shock. 8(1). 73–75. 57 indexed citations
10.
Samtleben, W., M Blumenstein, Thomas Bosch, Michael J. Lysaght, & B. Schmidt. (1996). Plasma Therapy at Klinikum Grosshadern: A 15‐Year Retrospective. Artificial Organs. 20(6). 408–413. 3 indexed citations
11.
Bosch, Thomas, B. Schmidt, M Blumenstein, & H. J. Gurland. (1993). Lipid Apheresis by Hemoperfusion: In Vitro Efficacy and Ex Vivo Biocompatibility of a New Low‐Density Lipoprotein Adsorber Compatible with Human Whole Blood. Artificial Organs. 17(7). 640–652. 74 indexed citations
12.
Schiller, Brigitte, et al.. (1991). Monocyte Phenotype and Interleukin-1 Production in Patients Undergoing Haemodialysis. ˜The œNephron journals/Nephron journals. 59(4). 573–579. 10 indexed citations
13.
Ziegler-Heitbrock, H.W.L., et al.. (1991). Small (CD14<sup>+</sup>/CD16<sup>+</sup>) Monocytes and Regular Monocytes in Human Blood. Pathobiology. 59(3). 127–130. 32 indexed citations
14.
Blumenstein, M, et al.. (1990). Differential Activation of Monocytes in Haemodialysis Patients Exposed to Different Types of Membranes. Scandinavian Journal of Immunology. 31(2). 183–190. 13 indexed citations
15.
Sauer, H., et al.. (1990). Modulation of cytotoxicity of cytostatic drugs by hemodialysis in vitro and in vivo. Cancer Treatment Reviews. 17(2-3). 293–300. 16 indexed citations
16.
Ward, Richard, et al.. (1990). Evaluation of phagocytic cell function in an ex vivo model of hemodialysis. Kidney International. 37(2). 776–782. 20 indexed citations
17.
Blumenstein, M, et al.. (1988). Altered Interleukin-1 Production in Patients Undergoing Hemodialysis. ˜The œNephron journals/Nephron journals. 50(4). 277–281. 34 indexed citations
18.
Samtleben, W., et al.. (1984). Membrane plasma exchange: Principles and application techniques. Journal of Clinical Apheresis. 2(2). 163–169. 18 indexed citations
19.
Clemm, Ch., et al.. (1983). [Thrombopenia, hemolytic anemia and neurologic disorders].. PubMed. 24(4). 226–9. 1 indexed citations
20.
Blumenstein, M, et al.. (1981). CONTINUOUS CRYOFILTRATION (CCF) OF PLASMA FOR RHEUMATOID ARTHRITIS. 10(1). 110–113.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026